BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 19254360)

  • 1. Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type.
    Matsuoka S; Dam E; Lecossier D; Clavel F; Hance AJ
    Retrovirology; 2009 Mar; 6():21. PubMed ID: 19254360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells.
    Hatziioannou T; Perez-Caballero D; Cowan S; Bieniasz PD
    J Virol; 2005 Jan; 79(1):176-83. PubMed ID: 15596813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain-specific differences in the impact of human TRIM5alpha, different TRIM5alpha alleles, and the inhibition of capsid-cyclophilin A interactions on the infectivity of HIV-1.
    Battivelli E; Lecossier D; Matsuoka S; Migraine J; Clavel F; Hance AJ
    J Virol; 2010 Nov; 84(21):11010-9. PubMed ID: 20702630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
    Sokolskaja E; Berthoux L; Luban J
    J Virol; 2006 Mar; 80(6):2855-62. PubMed ID: 16501094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophilin A protects HIV-1 from restriction by human TRIM5α.
    Kim K; Dauphin A; Komurlu S; McCauley SM; Yurkovetskiy L; Carbone C; Diehl WE; Strambio-De-Castillia C; Campbell EM; Luban J
    Nat Microbiol; 2019 Dec; 4(12):2044-2051. PubMed ID: 31636416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A.
    Li Y; Kar AK; Sodroski J
    J Virol; 2009 Nov; 83(21):10951-62. PubMed ID: 19656870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity.
    Saphire AC; Bobardt MD; Gallay PA
    J Virol; 2002 Mar; 76(5):2255-62. PubMed ID: 11836403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the Viral Core.
    Selyutina A; Persaud M; Simons LM; Bulnes-Ramos A; Buffone C; Martinez-Lopez A; Scoca V; Di Nunzio F; Hiatt J; Marson A; Krogan NJ; Hultquist JF; Diaz-Griffero F
    Cell Rep; 2020 Mar; 30(11):3766-3777.e6. PubMed ID: 32187548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import.
    Veillette M; Bichel K; Pawlica P; Freund SM; Plourde MB; Pham QT; Reyes-Moreno C; James LC; Berthoux L
    Retrovirology; 2013 Feb; 10():25. PubMed ID: 23448277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in CypA Binding Region of HIV-1 Capsid Affect Capsid Stability and Viral Replication in Primary Macrophages.
    Setiawan LC; van Dort KA; Rits MA; Kootstra NA
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):390-8. PubMed ID: 26414211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.
    Sokolskaja E; Sayah DM; Luban J
    J Virol; 2004 Dec; 78(23):12800-8. PubMed ID: 15542632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.
    Brockman MA; Schneidewind A; Lahaie M; Schmidt A; Miura T; Desouza I; Ryvkin F; Derdeyn CA; Allen S; Hunter E; Mulenga J; Goepfert PA; Walker BD; Allen TM
    J Virol; 2007 Nov; 81(22):12608-18. PubMed ID: 17728232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophilin A potentiates TRIM5α inhibition of HIV-1 nuclear import without promoting TRIM5α binding to the viral capsid.
    Burse M; Shi J; Aiken C
    PLoS One; 2017; 12(8):e0182298. PubMed ID: 28767697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors.
    Kahl CA; Cannon PM; Oldenburg J; Tarantal AF; Kohn DB
    Gene Ther; 2008 Aug; 15(15):1079-89. PubMed ID: 18385767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.
    Keckesova Z; Ylinen LM; Towers GJ
    J Virol; 2006 May; 80(10):4683-90. PubMed ID: 16641261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells.
    Takeuchi H; Buckler-White A; Goila-Gaur R; Miyagi E; Khan MA; Opi S; Kao S; Sokolskaja E; Pertel T; Luban J; Strebel K
    J Virol; 2007 Aug; 81(15):8080-90. PubMed ID: 17522232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Tripartite Complex HIV-1 Tat-Cyclophilin A-Capsid Protein Enables Tat Encapsidation That Is Required for HIV-1 Infectivity.
    Schatz M; Marty L; Ounadjela C; Tong PBV; Cardace I; Mettling C; Milhiet PE; Costa L; Godefroy C; Pugnière M; Guichou JF; Mesnard JM; Blaise M; Beaumelle B
    J Virol; 2023 Apr; 97(4):e0027823. PubMed ID: 37129415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 with gag processing defects activates cGAS sensing.
    Sumner RP; Blest H; Lin M; Maluquer de Motes C; Towers GJ
    Retrovirology; 2024 May; 21(1):10. PubMed ID: 38778414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.
    Yap MW; Dodding MP; Stoye JP
    J Virol; 2006 Apr; 80(8):4061-7. PubMed ID: 16571822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA.
    De Iaco A; Luban J
    Retrovirology; 2014 Jan; 11():11. PubMed ID: 24479545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.